ＮＡＮＯ ＭＲＮＡ(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4571/E05728 | NanoCarrier Co., Ltd. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2013/08/09 | 日証協 | 23,916株 | +2.23% | 4,413株 | +59.31% | 18,514株 | +2.69% | 1,476株 | -51.16% |
| 2013/08/02 | 日証協 | 23,395株 | +3.14% | 2,770株 | +18.07% | 18,029株 | +7.82% | 3,022株 | +3114.89% |
| 2013/07/26 | 日証協 | 22,682株 | -12.09% | 2,346株 | +877.5% | 16,722株 | -12.54% | 94株 | -79.34% |
| 2013/07/19 | 日証協 | 25,802株 | -2.93% | 240株 | -94.93% | 19,119株 | -1.62% | 455株 | -82.04% |
| 2013/07/12 | 日証協 | 26,581株 | -3.77% | 4,737株 | -67.2% | 19,434株 | -4.88% | 2,533株 | +30.37% |
| 2013/07/05 | 日証協 | 27,622株 | -10.13% | 14,441株 | +11.51% | 20,430株 | -8.35% | 1,943株 | -66.36% |
| 2013/06/28 | 日証協 | 30,736株 | +2.51% | 12,950株 | +94.36% | 22,291株 | +1.41% | 5,776株 | -1.58% |
| 2013/06/21 | 日証協 | 29,983株 | -2.92% | 6,663株 | -22.33% | 21,982株 | -3.45% | 5,869株 | -51.58% |
| 2013/06/14 | 日証協 | 30,886株 | -21.27% | 8,579株 | -36.73% | 22,767株 | -19.96% | 12,121株 | -18.34% |
| 2013/06/07 | 日証協 | 39,232株 | -1.48% | 13,559株 | +115.94% | 28,443株 | -2.65% | 14,843株 | -3% |
| 2013/05/31 | 日証協 | 39,822株 | -3.11% | 6,279株 | -23.12% | 29,217株 | -4.09% | 15,302株 | +63.43% |
| 2013/05/24 | 日証協 | 41,100株 | -0.09% | 8,167株 | +79.77% | 30,464株 | +1.81% | 9,363株 | +2.57% |
| 2013/05/17 | 日証協 | 41,136株 | -6.01% | 4,543株 | -49.79% | 29,921株 | +11.25% | 9,128株 | +552.93% |
| 2013/05/10 | 日証協 | 43,767株 | +2.16% | 9,048株 | -61.13% | 26,896株 | -0.74% | 1,398株 | +103.49% |
| 2013/05/02 | 日証協 | 42,840株 | -4.85% | 23,276株 | +73.86% | 27,097株 | -11.1% | 687株 | -89.67% |
| 2013/04/26 | 日証協 | 45,023株 | +4.34% | 13,388株 | -47.92% | 30,479株 | +7.77% | 6,651株 | +24.55% |
| 2013/04/19 | 日証協 | 43,149株 | +17.43% | 25,709株 | +83.15% | 28,282株 | -2.42% | 5,340株 | -36.14% |
| 2013/04/12 | 日証協 | 36,745株 | +15.81% | 14,037株 | +69.8% | 28,983株 | +29.16% | 8,362株 | +63.42% |
| 2013/04/05 | 日証協 | 31,730株 | -14.2% | 8,267株 | -36.08% | 22,439株 | -2.85% | 5,117株 | +282.15% |
※株式分割は考慮していませんのでご注意ください。
Page Top